Member Content

Small Cap Research: AxoGen (AXGN) an Exciting Med-Tech Growth Stock

by admin | Apr 3, 2017

AxoGen (AXGN) is a $345M maker of surgical solutions for peripheral nerve injuries trading 5.8X EV/Sales for FY17 and 4.3X FY18. AXGN hit $41M in revenues in 2016, up from $10.9M in 2013, and is forecasting $77M for 2018, also expecting to be near p...

Please login to continue reading this article.

Options Hawk Max

$300 | 30 days

Options Hawk Trading Hub Live Chat
Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
Live Mock Portfolio
1 on 1 Access
Hawk’s Trader Toolbox
Street Research
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
Weekly and Monthly OpEx Sheets
Notable Options Database
OptionsHawk Quarterly Market Brief

More About this Plan

Options Hawk Elite

$149 | 30 days

Hawk’s Market Blitz
Spotlight Trades (2 Per Week)
Market Recap
Weekly Earnings Snapshots
OptionsHawk Research
Daily Options Radar
OptionHawk’s Weekly Radar Report
Options Hawk Market Outlook Access
Daily Earnings Grid
OptionsHawk Quarterly Market Brief

More About this Plan